Polymyxin B-immobilized fibre haemoperfusion reduces urinary 8-hydroxy-2′-deoxyguanosine levels in patients with septic shock

Clinical Intensive Care

Volumn 17, Issue 3-4, 2006, Pages 95-100

  Nakamura, T ^a   Kawagoe, Y ^a   Ueda, Y ^b   Node, K ^c   Koide, H ^d  

^a Shinmatsudo Central General Hospital   (Japan)

^b DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d KOTO HOSPITAL   (Japan)

Author keywords

8 OhdG; Endotoxin; Oxidative stress; PMX F; Septic shock

Indexed keywords

8 HYDROXYDEOXYGUANOSINE;

8 HYDROXYDEOXYGUANOSINE URINE LEVEL; ADULT; AGED; APACHE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DEVICE; DISEASE MARKER; ENDOTOXIN BLOOD LEVEL; ENDOTOXIN DETECTION; FEMALE; HEMOPERFUSION; HUMAN; MALE; POLYMYXIN B IMMOBILIZED FIBER; SEPTIC SHOCK; TREATMENT RESPONSE; URINE LEVEL;

EID: 50549083731     PISSN: 09563075     EISSN: 14737752     Source Type: Journal    
DOI: 10.1080/09563070701704135     Document Type: Article

References (37)

1. Salvemini, D. and Cuzzocrea, S. (2002) Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med, 33, pp. 1173-1185.
2. de Vega, JM Alonso, Diaz, J., Serrano, E. and Carbonell, LF. (2002) Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med, 30, pp. 1782-1786.
3. Sanikidze, TV, Tkhilava, NG, Papava, MB, Datunashvili, IV, Gongadze, MT, Gamrekelashvili, DD and Bakhutashvili, VI. (2006) Role of free nitrogen and oxygen radicals in the pathogenesis of lipopolysaccharide-induced endotoxemia. Bull Exp Biol Med, 141, pp. 211-215.
4. Kolls, JK. (2006) Oxidative stress in sepsis: A redox redux. J Clin Invest, 116, pp. 860-863.
5. Wu, LL, Chiou, CC, Chang, PY and Wu, JT. (2004) Urinary 8-OHdG: A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetes. Clin Chim Acta, 339, pp. 1-9.
6. Nishimura, T., Sasahara, T., Kiritoshi, S., Sonoda, K., Senokuchi, T., Matsuo, T., Kukidome, D., Wake, N., Matsumura, T. and Miyamura, N. (2003) Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care, 26, pp. 1507-1512.
7. Kimura, S., Yamauchi, H., Hibino, Y., Iwamoto, M., Sera, K. and Ogino, K. (2006) Evaluation of urinary 8-hydroxydeoxyguanine in healthy Japanese people. Basic Clin Pharmacol Toxicol, 98, pp. 496-502.
8. Endo, K., Miyashita, Y., Sasaki, H., Ebisuno, M., Ohira, M., Saiki, A., Koide, N., Oyama, T., Takeyoshi, M. and Shirai, K. (2006) Probucol and atorvastatin decreased urinary 8-hydroxy-2′-deoxyguanosine in patients with diabetes and hypercholesterolemia. J Atheroscler Thromb, 13, pp. 68-75.
9. Shoji, H. (2003) Extracorporeal endotoxin removal for the treatment of sepsis: Endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial, 7, pp. 108-114.
10. Tani, T., Hanasawa, K., Kodama, M., Imaizumi, H., Yonekawa, M., Saito, M., Ikeda, T., Yagi, Y., Takayama, K. and Amano, I. (2001) Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg, 25, pp. 660-668.
11. Vincent, JL, Laterre, PF, Cohen, J., Burchardi, H., Bruining, H., Lerma, FA, Wittebole, X., De Backer, D., Brett, S. and Marzo, D. (2005) A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock, 23, pp. 400-405.
12. Nakamura, T., Matsuda, T., Suzuki, Y., Shoji, H. and Koide, H. (2003) Polymyxin B-immobilized fiber hemoperfusion in patients with sepsis. Dial Transplant, 32, pp. 602-607.
13. Nakamura, T., Kawagoe, Y., Suzuki, T., Shoji, H., Ueda, Y., Kobayashi, N. and Koide, H. (2005) Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock. Blood Purif, 23, pp. 417-420.
14. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med, 20, pp. 864-874.
15. Vincent, JL, Moreno, R., Takala, J., Willatts, S., De Mendonca, A., Bruining, H., Reinhart, CK and Suter, PM. (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-related Problems of the European Society of Intensive Care Medicine. Intens Care Med, 22, pp. 707-710.
16. Knaus, WA, Draper, EA, Wagner, DP and Zimmerman, JE. (1985) APACHE II: A severity of disease classification system. Crit Care Med, 13, pp. 818-829.
17. Igishi, T., Hitsuda, Y., Kato, K., Sako, T., Burioka, N., Yasuda, K., Sano, H., Shigeoka, Y., Nakanishi, H. and Shimizu, E. (2003) Elevated urinary 8-hydroxydeoxyguanosine, a biomarker of oxidative stress, and lack of association with antioxidant vitamins in chronic obstructive pulmonary disease. Respirology, 8, pp. 455-460.
18. Sato, S., Mizuno, Y. and Hattiori, N. (2005) Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease. Neurology, 64, pp. 1081-1083.
19. Hata, I., Kaji, M., Hirano, S., Shigematsu, Y., Tsukahara, H. and Mayumi, M. (2006) Urinary oxidative stress markers in young patients with type 1 diabetes. Pediatr Int, 48, pp. 58-61.
20. Kanaya, S., Ikeya, M., Yamamoto, K., Moriya, T., Furuhashi, K., Sonoda, M., Goto, K. and Ochi, H. (2004) Comparison of an oxidative stress biomarker "urinary 8-hydroxy-2′-deoxyguanosine" between smokers and non-smokers. Biofactors, 22, pp. 255-258.
21. Kushi, H., Miki, T., Okamoto, K., Nakahara, J., Saito, T. and Tanjoh, K. (2005) Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care, 9, pp. 653-661.
22. Kohro, S., Imaizumi, H., Yamakage, M., Matsuda, Y., Namiki, A., Asai, Y. and Maruyama, I. (2006) Anandamide adsorption by direct hemoperfusion with polymyxin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. J Anesth, 20, pp. 11-16.
23. Toyokuni, S., Tanaka, T., Hattori, Y., Nishiyama, Y., Yoshida, A., Uchida, K., Hiai, H., Ochi, H. and Osawa, T. (1997) Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: Its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest, 76, pp. 365-374.
24. Saito, S., Yamauchi, H., Hasui, Y., Kurashige, J., Ochi, H. and Yoshida, K. (2000) Quantitative determination of urinary 8-hydroxydeoxyguanosine (8-OH-dG) by using ELISA. Res Commun Mol Pathol Pharmacol, 107, pp. 39-44.
25. Mishra, V., Baines, M., Wenstone, R. and Shenkin, A. (2005) Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Clin Biochem, 42, pp. 269-276.
26. Motoyama, T., Okamoto, K., Kukita, I., Hamaguchi, M., Kinoshita, Y. and Ogawa, H. (2003) Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med, 31, pp. 1048-1052.
27. Maeshima, E., Liang, XM, Goda, M., Otani, H. and Mune, M. (2007) The efficacy of vitamin E against oxidative damage and autoantibody production in systemic lupus erythematosus: A preliminary study. Clin Rheumatol, 26, pp. 401-404.
28. Tsukahara, M. (2007) Biomarkers for oxidative stress: Clinical application in pediatric medicine. Curr Med Chem, 14, pp. 339-351.
29. Vincent, JL. (2006) Organ dysfunction in patients with severe sepsis. Surg Infect (Larchmt), 7, p. S69.
30. Mishra, DP and Dhali, A. (2007) Endotoxin induces luteal cell apoptosis through the mitochondrial pathway. Prostagl Other Lipid Mediat, 83, pp. 79-88.
31. Li, L., Shoji, W., Takano, H., Nishimura, N., Aoki, Y., Takahashi, R., Goto, S., Kaifu, T., Takai, T. and Obinata, M. (2007) Increased susceptibility of MER5 knockout mice to LPS-induced oxidative stress. Biochem Biophys Res Commun, 35, pp. 715-721.
32. Sakaguchi, S. and Furusawa, S. (2006) Oxidative stress and septic shock metabolic aspects of oxygen-derived free radicals generation in the liver during endotoxemia. FEMS Immunol Med Microbiol, 47, pp. 167-177.
33. Crimi, E., Sica, V., Williams-Ignarro, S., Zhang, H., Slutsky, AS, Ignarro, LJ and Napoli, C. (2006) The role of oxidative stress in adult critical care. Free Radical Biol Med, 40, pp. 398-406.
34. Heyland, DK, Dhaliwal, R., Suchner, U. and Berger, MM. (2005) Antioxidant nutrients: A systemic review of trace elements and vitamins in the critically ill patients. Intens Care Med, 31, pp. 327-337.
35. Nathens, AB, Neff, MJ, Jurkovich, GJ, Klotz, P., Farver, K., Ruzinski, JT, Radella, F., Garcia, I. and Maier, RV. (2002) Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg, 236, pp. 814-822.
36. Abiles, J., de la Cruz, AP, Castano, J., Rodriguez-Eluira, M., Aguayo, E., Moreno-Torres, R., Liopis, J., Aranda, P., Arguelles, S. and Ayala, A. (2006) Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent severity: A cohort study. Crit Care, 10, p. R146.
37. Naka, T., Shinozaki, M., Okizawa, T., Shima, Y., Takaesu, H. and Nasu, H. (2006) The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock. Ther Apher Dial, 10, pp. 7-11.